In the US, Plaquenil (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis and Systemic Lupus Erythematosus.

US matches:

• Plaquenil

Ingredient matches for Plaquenil

Hydroxychloroquine

Hydroxychloroquine is reported as an ingredient of Plaquenil in the following countries:

• Tunisia
• United States

Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Plaquenil in the following countries:

• Argentina
• Australia
• Belgium
• Canada
• China
• Cyprus
• Czech Republic
• Denmark
• Egypt
• Estonia
• France
• Georgia
• Greece
• Hong Kong
• Iceland
• Ireland
• Israel
• Italy
• Japan
• Kuwait
• Latvia
• Lithuania
• Malaysia
• Malta
• Mexico
• Netherlands
• New Zealand
• Norway
• Philippines
• Romania
• Slovakia
• Sweden
• Taiwan
• Thailand
• Turkey